ArticleBMJ public health2025
Changes in inpatient and outpatient stroke admissions during COVID-19: a difference-in-differences analysis based on claims data from 242 acute care hospitals in Japan.
Article in BMJ public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: While COVID-19 has been associated with an elevated stroke risk due to its prothrombotic and inflammatory effects, previous studies have reported a decreased number of stroke hospitalisations during COVID-19. Patients with a stroke who could not be admitted might have been followed up in outpatient settings of these hospitals. Our study aimed to investigate the change in the number of patients who had a stroke admitted to inpatient and outpatient settings during COVID-19. Methods: A difference-in-differences design using claims data in 242 acute-care hospitals was adopted to examine stroke admissions in Japan, contrasting the pre-pandemic period (2015-2019) to the pandemic period (2020). The Japanese government's declaration of emergency in April 2020 was considered an exogenous shock. The outcomes were the numbers of ischaemic stroke (both embolic and non-embolic), intracerebral haemorrhage and subarachnoid haemorrhage admissions, with in-hospital mortality rates, modified Rankin Scale and procedure uses. Results: From a total of 27 631 stroke cases (44.3% women, median age 75 years (IQR 66-83)), no statistically significant changes were observed in the overall count of stroke admissions during the pandemic. A decrease in ischaemic stroke hospitalisations was detected (incidence-rate ratios (95% CI), 0.83 (0.73 to 0.95)), which was somewhat offset by an increasing trend for patients treated in the outpatient setting (1.06 (0.91 to 1.22)). No significant differences were found in in-hospital mortality rate, proportion of severe modified Rankin Scale at discharge and thrombolysis treatment rate. Rates of mechanical thrombectomy in ischaemic stroke were reduced (0.60 (0.36 to 0.99)), and length of stay was reduced for all types of stroke except intracerebral haemorrhage. Conclusion: When considering both inpatient and outpatient admissions for stroke, we found no statistically significant change in the number of stroke admissions in 2020 in Japan. In addition, our findings suggest that acute stroke inpatient care, at least during 2020, was appropriately managed despite limited resources.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.